chr4-10021215-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020041.3(SLC2A9):​c.150+65C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0683 in 1,553,604 control chromosomes in the GnomAD database, including 8,868 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1428 hom., cov: 33)
Exomes 𝑓: 0.065 ( 7440 hom. )

Consequence

SLC2A9
NM_020041.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.753

Publications

5 publications found
Variant links:
Genes affected
SLC2A9 (HGNC:13446): (solute carrier family 2 member 9) This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
SLC2A9-AS1 (HGNC:40636): (SLC2A9 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 4-10021215-G-A is Benign according to our data. Variant chr4-10021215-G-A is described in ClinVar as Benign. ClinVar VariationId is 1182363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.445 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020041.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC2A9
NM_020041.3
MANE Select
c.150+65C>T
intron
N/ANP_064425.2
SLC2A9
NM_001001290.2
c.64-2142C>T
intron
N/ANP_001001290.1Q9NRM0-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC2A9
ENST00000264784.8
TSL:1 MANE Select
c.150+65C>T
intron
N/AENSP00000264784.3Q9NRM0-1
SLC2A9
ENST00000309065.7
TSL:1
c.64-2142C>T
intron
N/AENSP00000311383.3Q9NRM0-2
SLC2A9
ENST00000505104.5
TSL:1
n.185-2142C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.103
AC:
15704
AN:
152122
Hom.:
1414
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.175
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.100
Gnomad ASJ
AF:
0.0703
Gnomad EAS
AF:
0.461
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.0728
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.0366
Gnomad OTH
AF:
0.0908
GnomAD4 exome
AF:
0.0645
AC:
90411
AN:
1401364
Hom.:
7440
AF XY:
0.0661
AC XY:
46315
AN XY:
700338
show subpopulations
African (AFR)
AF:
0.179
AC:
5770
AN:
32288
American (AMR)
AF:
0.120
AC:
5330
AN:
44554
Ashkenazi Jewish (ASJ)
AF:
0.0712
AC:
1835
AN:
25756
East Asian (EAS)
AF:
0.466
AC:
18349
AN:
39362
South Asian (SAS)
AF:
0.143
AC:
12145
AN:
84892
European-Finnish (FIN)
AF:
0.0721
AC:
3816
AN:
52890
Middle Eastern (MID)
AF:
0.105
AC:
428
AN:
4082
European-Non Finnish (NFE)
AF:
0.0356
AC:
37722
AN:
1059288
Other (OTH)
AF:
0.0861
AC:
5016
AN:
58252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4098
8197
12295
16394
20492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1770
3540
5310
7080
8850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.103
AC:
15754
AN:
152240
Hom.:
1428
Cov.:
33
AF XY:
0.108
AC XY:
8003
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.175
AC:
7287
AN:
41542
American (AMR)
AF:
0.100
AC:
1533
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0703
AC:
244
AN:
3472
East Asian (EAS)
AF:
0.460
AC:
2381
AN:
5172
South Asian (SAS)
AF:
0.162
AC:
782
AN:
4822
European-Finnish (FIN)
AF:
0.0728
AC:
773
AN:
10614
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.0367
AC:
2493
AN:
67994
Other (OTH)
AF:
0.0951
AC:
201
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
665
1329
1994
2658
3323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0946
Hom.:
327
Bravo
AF:
0.110
Asia WGS
AF:
0.276
AC:
956
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.4
DANN
Benign
0.73
PhyloP100
-0.75
PromoterAI
-0.043
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276963; hg19: chr4-10022839; COSMIC: COSV53319943; COSMIC: COSV53319943; API